NAD reviews hair-loss product
This article was originally published in The Rose Sheet
Executive SummaryLifes2Good Natural Healthcare has been advised to modify advertising for its Viviscal dietary supplement - which nourishes the hair follicle with vitamin C, silica and glycosaminoglycans - to assure it is gender-neutral, according to the National Advertising Division. The ads in question included radio, print and Internet ads, including one that featured the testimonial of an actress and "health enthusiast" along with the statement that one in three women will be affected by thinning hair during their lifetime. The Council of Better Business Bureaus division determined that because the studies supporting the efficacy of the product were only conducted on men, the advertiser should revise ads to avoid indicating that the product has been shown to work in women. NAD also recommended the firm discontinue claims asserting that the product is "doctor recommended." Lifes2Good was able to substantiate one claim: "Recommended by top celebrities and models." Though Lifes2Good says it disagrees with NAD's decision regarding the gender focus of its ads, it will comply with the watchdog's recommendation
You may also be interested in...
AstraZeneca/Daiichi Sankyo and Seattle Genetics presented exciting data at SABCS on drugs that extended survival in patients who had exhausted most treatment options.
US FDA officials tell industry that implementing a quality metrics program is an agency priority and that a rejiggered program will incorporate various elements of other quality metrics initiatives being piloted by the agency, industry and academia.
Sanofi eyes $1bn top line growth from OTC switches of ED drug Cialis and flu drug Tamiflu after they launch by 2026, says CEO Paul Hudson. Like switch consultants, though, he acknowledges the high bar for approval moving additional Rx ingredients to OTC.